Center of Excellence in Advanced Pharmaceutical Technologies
Masaryk University (MU) is the second-largest university in the Czech Republic located in Brno. Thanks to the ESIF funding, MU was able to acquire top research infrastructure attracting talented researchers who gradually built the...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EUIN2013-51211
INNOVATIVE TRAINING NETWORK (ITN) IN NANOMEDICINE
23K€
Cerrado
PCIN-2016-085
SUPERFICIES BIOACTIVAS NANOESTRUCTURADAS DISEÑADAS PARA MEDI...
90K€
Cerrado
CTQ2015-64538-R
NANOQUIMICA CON BACTERIAS, BIOPOLIMEROS Y BIOFIBRAS
85K€
Cerrado
BES-2009-025077
DESARROLLO DE PEPTIDOS FOTOCONMUTABLES CON APLICACIONES BIOL...
49K€
Cerrado
JCI-2011-10737
Novel biomaterials and advanced drug carrier systems includi...
96K€
Cerrado
RED2018-102417-T
RED DE PEPTIDOS EN BIOMEDICINA Y NANOCIENCIA
20K€
Cerrado
Información proyecto ExcellPharmTech
Duración del proyecto: 64 meses
Fecha Inicio: 2022-10-20
Fecha Fin: 2028-02-29
Líder del proyecto
Masarykova univerzita
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
2M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Masaryk University (MU) is the second-largest university in the Czech Republic located in Brno. Thanks to the ESIF funding, MU was able to acquire top research infrastructure attracting talented researchers who gradually built the position of the MU as the top regional hub for education, research, and innovation.
To further exploit this potential, the management structures and processes of the university must thoroughly implement the European Research Area (ERA) Priorities. As an outstanding researcher/innovator can have a decisive and positive impact on the culture and performance of any institution, MU will recruit a world-class research manager as an ERA Chair for its newly-established Faculty of Pharmacy.
The Faculty of Pharmacy (MUNI Pharm) is, besides others, focused on the development of advanced drug formulations and molecular biology techniques. The ERA Chair will intensify the research and development of advanced drug formulation and nanotechnologies to open new opportunities to intensify MUNI Pharm research capacities in the field of pharmacy and develop strategic partnerships with the application sphere and public sector for faster translation of the advanced drugs into clinics.
The recruitment of leading scientist will enforce the connection of the MUNI Pharm to research structures of MU, and the ERA Chair will make a bridge in the formation of unique education and research facility at one place titled MUNI BioPharma Hub, supported from National Recovery Plan (part of RRF – Recovery and Resilience Facility, NextGeneration EU).
To solve the targeted delivery and transportation of nucleic acids into target cell environment, the MUNI Pharm will establish an interdisciplinary center of excellence (Pharma Center of Excellence in Advanced Technology) with prof. David Oupický as its leader. The creation of an international ERA Chair team will ensure a successful establishment of the center combining excellent research, high level education and top innovations.